DISCOVERY AND DEVELOPMENT PROGRAMS
Partnering
We believe impactful science starts with true collaboration. As a leader in peptide drug discovery and development, we combine deep scientific expertise with a strong partnership mindset. With more than 10 partnerships across biotech and pharma, we work together to explore new biology, develop innovative therapeutics, and deliver real-world impact.
Why Gubra?
-
- Trusted collaboration partner with extensive biotech, pharma, and academic networks
- Deep scientific expertise in peptide drug discovery and development across diverse therapeutic areas
- Proven ability to advance bold scientific ideas toward therapeutic applications
- Agile approach to co-creation and partnership-driven innovation
Consult with Line Holten Reimer
Choose the right, trustworthy discovery partner.
Key Figures
From advanced in vivo pharmacology models to proprietary machine learning technologies, we bring an unparalleled experimental backbone to every program. This enables faster iteration, richer data, and better decision-making at every stage of discovery – accelerating progress and creating a foundation for mutual success.
10
Alliances Built Through the Years
Long-term trusted alliance partners
6
Active Partnerships
Across several different indications
3
Programs in Clinical Development
Three partnered projects in phase 1 or beyond
How we work
Diverse and Strategic Partnerships
We collaborate with pharmaceutical and biotech companies as well as leading academic institutions. As a trusted and competent partner, we specialize in discovery, preclinical research, and early clinical development.
One Team or Independent Partner
We collaborate as equals, bringing complementary strengths to the table. Whether fully integrated with your team or operating independently under shared direction, we adapt to what the science and strategy require. The structure is flexible, the commitment is mutual.
Flexible Deal-Making
We build partnerships that align science and strategy. Our deal-making is pragmatic and creative but always with a focus on shared value, shared risk, and shared upside. We’re in it to build, together.
Selected partners
Boehringer Ingelheim
Since 2017, Gubra and Boehringer Ingelheim have established a series of collaborative agreements focused on discovering and developing novel peptide-based treatments for obesity, combining Gubra’s streaMLine platform and expertise in peptide chemistry with Boehringer Ingelheim’s clinical development capabilities. This partnership has advanced multiple drug candidates into clinical development, including BI 3034701, a long-acting triple agonist peptide currently in Phase 1 trials.
AbbVie
In 2025, Gubra and AbbVie entered into a global license agreement to develop and commercialize GUBamy (GUB014295), a long-acting amylin analog designed for weight management in individuals with obesity. This collaboration leverages Gubra’s expertise in peptide drug discovery and AbbVie’s capabilities in clinical development and commercialization.
Amylyx Pharmaceuticals
In 2024, Gubra and Amylyx Pharmaceuticals initiated a collaboration to develop a novel long-acting GLP-1 receptor antagonist, combining Gubra’s AI-driven streaMLine platform for peptide discovery with Amylyx’ expertise in developing novel therapies for communities with high unmet needs.
Discovery Programs
Partnering Team
Our Partnering Team brings together a unique mix of expertise from biotech and pharma, with backgrounds in business development, research, project and portfolio management, venture financing, and corporate finance. We have a solid track record in deal-making, supporting partnerships from early innovation to late-stage development and in-market products. Our team blends scientific insight with commercial acumen to create collaborations built on trust and long-term value.
Let’s connect and explore new opportunities together
Louise S. Dalbøge
Chief Science Officer (CSO)
Line Holten Reimer
Head of Business Development
Lise Biehl Rudkjær
Senior BD Director
Jacob Lange Moresco
Senior BD Director
Related pages
For further information
Contact us
Gubra
Hørsholm Kongevej 11B
2970 Hørsholm
Denmark
+45 3152 2650